Guangzhou Boji Medical and Biotechnological Co Ltd (300404) — Capital Reinvestment Ratio
Guangzhou Boji Medical and Biotechnological Co Ltd (300404) has a Capital Reinvestment Ratio of 4.18x as of June 2022, meaning it reinvests 4% of its operating cash flow (CN¥7.44 Million) in capital expenditures (CN¥31.14 Million). See 300404 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Boji Medical and Biotechnological Co Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Guangzhou Boji Medical and Biotechnological Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Guangzhou Boji Medical and Biotechnological Co Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Guangzhou Boji Medical and Biotechnological Co Ltd from 2012 to 2025. For live market cap and broader valuation context, see 300404 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥87.01 Million | CN¥18.71 Million | ▼ -80.4% |
| 2024 | 1.10x | CN¥26.78 Million | CN¥29.35 Million | ▼ -36.6% |
| 2023 | 1.73x | CN¥35.95 Million | CN¥62.20 Million | ▼ -58.7% |
| 2022 | 4.18x | CN¥28.14 Million | CN¥117.73 Million | ▲ +133.3% |
| 2021 | 1.79x | CN¥30.10 Million | CN¥53.99 Million | ▲ +454.0% |
| 2020 | 0.32x | CN¥97.07 Million | CN¥31.42 Million | ▼ -99.9% |
| 2019 | 337.76x | CN¥85.87K | CN¥29.00 Million | ▲ +23930.0% |
| 2018 | 1.41x | CN¥27.06 Million | CN¥38.03 Million | ▼ -41.0% |
| 2017 | 2.38x | CN¥26.22 Million | CN¥62.47 Million | ▼ -67.1% |
| 2015 | 7.24x | CN¥1.93 Million | CN¥13.94 Million | ▲ +723.1% |
| 2014 | 0.88x | CN¥25.69 Million | CN¥22.60 Million | ▲ +1205.4% |
| 2013 | 0.07x | CN¥43.48 Million | CN¥2.93 Million | ▼ -80.1% |
| 2012 | 0.34x | CN¥41.40 Million | CN¥14.03 Million | — |